您的购物车当前为空
别名 蛋白酶体抑制剂
Lactacystin是一种口服活性、不可逆的细胞渗透性蛋白酶体抑制剂(IC50=4.8 μM),还能抑制溶酶体酶cathepsin A,诱导细胞凋亡和周期阻滞,具有抗癌、抗病毒和抗氧化活性,能穿透血脑屏障,常用于帕金森症和痴呆症模型构建。

Lactacystin是一种口服活性、不可逆的细胞渗透性蛋白酶体抑制剂(IC50=4.8 μM),还能抑制溶酶体酶cathepsin A,诱导细胞凋亡和周期阻滞,具有抗癌、抗病毒和抗氧化活性,能穿透血脑屏障,常用于帕金森症和痴呆症模型构建。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 50 μg | ¥ 1,230 | In Stock | |
| 100 μg | ¥ 1,990 | In Stock | |
| 1 mg | ¥ 6,680 | In Stock |
Lactacystin 相关产品
| 产品描述 | Lactacystin is an orally active, irreversible, and cell-permeable proteasome inhibitor (IC50 = 4.8 μM) that also inhibits the lysosomal enzyme cathepsin A. It induces apoptosis and cell cycle arrest, possesses anticancer, antiviral, and antioxidant activities, can penetrate the blood-brain barrier, and is commonly used in the construction of Parkinson’s disease and dementia models. |
| 靶点活性 | Proteasome:4.8 μM |
| 体外活性 | 方法:Lactacystin(2.5–10 μg/ml,48小时)处理 RA 分化的 SH-SY5Y 细胞,以选择用于 celastrol 研究的有效浓度。 |
| 体内活性 | 方法:Lactacystin(5 μg/2 μl) 单侧给药到大鼠左侧 SNc 中 ,研究对大鼠体重的影响。 |
| 别名 | 蛋白酶体抑制剂 |
| 分子量 | 376.43 |
| 分子式 | C15H24N2O7S |
| CAS No. | 133343-34-7 |
| Smiles | C(SC[C@H](NC(C)=O)C(O)=O)(=O)[C@@]1([C@H](C(C)C)O)[C@@H](O)[C@@H](C)C(=O)N1 |
| 密度 | 1.367 g/cm3 |
| 颜色 | Transparent |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
| 溶解度信息 | DMSO: 18 mg/mL (47.82 mM), Sonication and heating are recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||
评论内容